Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans

Vanessa L. Cropley, Masahiro Fujita, John L. Musachio, Jinsoo Hong, Subroto Ghose, Janet Sangare, Pradeep J. Nathan, Victor W. Pike, Robert B. Innis

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The present study estimated radiation-absorbed doses of the dopamine D 1 receptor radioligand [11C]((1)-8-chloro-5-(7- benzofuranyl)-7-hydroxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine) (NNC 112) in humans, based on dynamic whole-body PET in healthy subjects. Methods: Whole-body PET was performed on 7 subjects after injection of 710 ± 85 MBq of 11C-NNC 112. Fourteen frames were acquired for a total of 120 min in 7 segments of the body. Regions of interest were drawn on compressed planar images of source organs that could be identified. Radiation dose estimates were calculated from organ residence times using the OLINDA 1.0 program. Results: The organs with the highest radiation-absorbed doses were the gall-bladder, liver, lungs, kidneys, and urinary bladder wall. Biexponential fitting of mean bladder activity demonstrated that 15% of activity was excreted via the urine. With a 2.4-h voiding interval, the effective dose was 5.7 μSv/MBq (21.1 mrem/mCi). Conclusion: 11C-NNC 112 displays a favorable radiation dose profile in humans and would allow multiple PET examinations per year to be performed on the same subject.

Original languageEnglish (US)
Pages (from-to)100-104
Number of pages5
JournalJournal of Nuclear Medicine
Volume47
Issue number1
StatePublished - Jan 1 2006

Fingerprint

Dopamine D1 Receptors
Radiation
Urinary Bladder
Dopamine
Healthy Volunteers
Urine
Kidney
Lung
Injections
NNC 112
Liver

Keywords

  • C-NNC 112
  • D receptor
  • Dosimetry
  • Effective dose
  • PET

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Cropley, V. L., Fujita, M., Musachio, J. L., Hong, J., Ghose, S., Sangare, J., ... Innis, R. B. (2006). Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans. Journal of Nuclear Medicine, 47(1), 100-104.

Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans. / Cropley, Vanessa L.; Fujita, Masahiro; Musachio, John L.; Hong, Jinsoo; Ghose, Subroto; Sangare, Janet; Nathan, Pradeep J.; Pike, Victor W.; Innis, Robert B.

In: Journal of Nuclear Medicine, Vol. 47, No. 1, 01.01.2006, p. 100-104.

Research output: Contribution to journalArticle

Cropley, VL, Fujita, M, Musachio, JL, Hong, J, Ghose, S, Sangare, J, Nathan, PJ, Pike, VW & Innis, RB 2006, 'Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans', Journal of Nuclear Medicine, vol. 47, no. 1, pp. 100-104.
Cropley, Vanessa L. ; Fujita, Masahiro ; Musachio, John L. ; Hong, Jinsoo ; Ghose, Subroto ; Sangare, Janet ; Nathan, Pradeep J. ; Pike, Victor W. ; Innis, Robert B. / Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans. In: Journal of Nuclear Medicine. 2006 ; Vol. 47, No. 1. pp. 100-104.
@article{ca917e10d33a4f4b9f853f26b6470bc0,
title = "Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans",
abstract = "The present study estimated radiation-absorbed doses of the dopamine D 1 receptor radioligand [11C]((1)-8-chloro-5-(7- benzofuranyl)-7-hydroxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine) (NNC 112) in humans, based on dynamic whole-body PET in healthy subjects. Methods: Whole-body PET was performed on 7 subjects after injection of 710 ± 85 MBq of 11C-NNC 112. Fourteen frames were acquired for a total of 120 min in 7 segments of the body. Regions of interest were drawn on compressed planar images of source organs that could be identified. Radiation dose estimates were calculated from organ residence times using the OLINDA 1.0 program. Results: The organs with the highest radiation-absorbed doses were the gall-bladder, liver, lungs, kidneys, and urinary bladder wall. Biexponential fitting of mean bladder activity demonstrated that 15{\%} of activity was excreted via the urine. With a 2.4-h voiding interval, the effective dose was 5.7 μSv/MBq (21.1 mrem/mCi). Conclusion: 11C-NNC 112 displays a favorable radiation dose profile in humans and would allow multiple PET examinations per year to be performed on the same subject.",
keywords = "C-NNC 112, D receptor, Dosimetry, Effective dose, PET",
author = "Cropley, {Vanessa L.} and Masahiro Fujita and Musachio, {John L.} and Jinsoo Hong and Subroto Ghose and Janet Sangare and Nathan, {Pradeep J.} and Pike, {Victor W.} and Innis, {Robert B.}",
year = "2006",
month = "1",
day = "1",
language = "English (US)",
volume = "47",
pages = "100--104",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "1",

}

TY - JOUR

T1 - Whole-body biodistribution and estimation of radiation-absorbed doses of the dopamine D1 receptor radioligand 11C-NNC 112 in humans

AU - Cropley, Vanessa L.

AU - Fujita, Masahiro

AU - Musachio, John L.

AU - Hong, Jinsoo

AU - Ghose, Subroto

AU - Sangare, Janet

AU - Nathan, Pradeep J.

AU - Pike, Victor W.

AU - Innis, Robert B.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - The present study estimated radiation-absorbed doses of the dopamine D 1 receptor radioligand [11C]((1)-8-chloro-5-(7- benzofuranyl)-7-hydroxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine) (NNC 112) in humans, based on dynamic whole-body PET in healthy subjects. Methods: Whole-body PET was performed on 7 subjects after injection of 710 ± 85 MBq of 11C-NNC 112. Fourteen frames were acquired for a total of 120 min in 7 segments of the body. Regions of interest were drawn on compressed planar images of source organs that could be identified. Radiation dose estimates were calculated from organ residence times using the OLINDA 1.0 program. Results: The organs with the highest radiation-absorbed doses were the gall-bladder, liver, lungs, kidneys, and urinary bladder wall. Biexponential fitting of mean bladder activity demonstrated that 15% of activity was excreted via the urine. With a 2.4-h voiding interval, the effective dose was 5.7 μSv/MBq (21.1 mrem/mCi). Conclusion: 11C-NNC 112 displays a favorable radiation dose profile in humans and would allow multiple PET examinations per year to be performed on the same subject.

AB - The present study estimated radiation-absorbed doses of the dopamine D 1 receptor radioligand [11C]((1)-8-chloro-5-(7- benzofuranyl)-7-hydroxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine) (NNC 112) in humans, based on dynamic whole-body PET in healthy subjects. Methods: Whole-body PET was performed on 7 subjects after injection of 710 ± 85 MBq of 11C-NNC 112. Fourteen frames were acquired for a total of 120 min in 7 segments of the body. Regions of interest were drawn on compressed planar images of source organs that could be identified. Radiation dose estimates were calculated from organ residence times using the OLINDA 1.0 program. Results: The organs with the highest radiation-absorbed doses were the gall-bladder, liver, lungs, kidneys, and urinary bladder wall. Biexponential fitting of mean bladder activity demonstrated that 15% of activity was excreted via the urine. With a 2.4-h voiding interval, the effective dose was 5.7 μSv/MBq (21.1 mrem/mCi). Conclusion: 11C-NNC 112 displays a favorable radiation dose profile in humans and would allow multiple PET examinations per year to be performed on the same subject.

KW - C-NNC 112

KW - D receptor

KW - Dosimetry

KW - Effective dose

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=34248667292&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248667292&partnerID=8YFLogxK

M3 - Article

C2 - 16391193

AN - SCOPUS:34248667292

VL - 47

SP - 100

EP - 104

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 1

ER -